1-8 of 8
Daniela Nicoleta Petrusca
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unraveling the Kinase-Independent Autoregulatory Mechanism of PIM2 in Multiple Myeloma

Christopher Rolf Schorr, Daniela Nicoleta Petrusca, Louise Carlson, Joyce Hardwick, Julia Grace Reinke, Kelvin P. Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 4666.
https://doi.org/10.1182/blood-2024-193753
Published: 2024
Journal Articles

Role of Tryptophan Metabolizing Enzymes in Multiple Myeloma Survival

Julia Grace Reinke, Peng Peng, Daniela Nicoleta Petrusca, Kanita Chaudhry, Louise Carlson, Christopher Rolf Schorr, Kelvin P. Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 3350.
https://doi.org/10.1182/blood-2024-211044
Published: 2024
Journal Articles

GFI1-Dependent SGPP1 Repression Promotes Growth and Survival of Myeloma Cells

Daniela Nicoleta Petrusca, PhD, Evgeny Berdyshev, PhD, Colin D. Crean, BS, Judith L Anderson, BS, G. David Roodman, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4387.
https://doi.org/10.1182/blood-2019-131106
Published: 2019
Journal Articles

Targeting the p62-ZZ/N-End Rule Pathway in Multiple Myeloma Overcomes Proteasome Inhibitor-Resistance Via Induction of Necroptosis and Enhances the Bone Anabolic Effects of Proteasome Inhibitors

Silvia Marino, PhD, Daniela Nicoleta Petrusca, PhD, Edward Simpson, PhD, Judith L Anderson, BS, Xiang-Qun Xie, PhDMD,MBA, Yunlong Liu, PhD, John Chirgwin, PhD, G. David Roodman, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4391.
https://doi.org/10.1182/blood-2019-131865
Published: 2019
Journal Articles

Identification of Beta-Catenin As a Novel Ubiquitin-Regulated Target of Combined FlĪ²3/Syk- and Proteasome Inhibitors for Interruption of LSC Signaling in Poor-Risk AML

Sravanti Rangaraju, MBBS, Silvia Marino, PhD, Daniela Nicoleta Petrusca, PhD, Larry D Cripe, MD, Katie J Sargent, RN, G. David Roodman, MD PhD, Hamid Sayar, MD MSc, Baskar Ramdas, PhD, Lakshmi Reddy Palam, PhD, Rajasubramaniam Shanmugam, PhD, Adriana Rogozea, Heiko Konig, MD PhD, Reuben Kapur, PhD, H. Scott Boswell, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3949.
https://doi.org/10.1182/blood-2018-99-111181
Published: 2018
Journal Articles

The Gfi1-SphK1 Axis Regulates the Growth and Survival of Myeloma Cells

Daniela Nicoleta Petrusca, PhD, Evgeny Berdyshev, PhD, Patrick Mulcrone, PhD, Colin D. Crean, BS, Judith L Anderson, BS, Quanhong Sun, PhD, Deborah Lynn Galson, PhD, G. David Roodman, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5615.
https://doi.org/10.1182/blood-2018-99-119507
Published: 2018
Journal Articles

Inhibition of p62-ZZ Domain-Mediated Signaling Overcomes Bortezomib Resistance in Multiple Myeloma Cells Independent of Their p53 Status

Silvia Marino, PhD, Daniela Nicoleta Petrusca, PhD, Rebecca Silberman, MD, Denise Toscani, PhD, Judith L Anderson, Nicola Giuliani, MD PhD, Xiang-Qun Xie, PhD, Noriyoshi Kurihara, DDS, PhD, G David Roodman, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4421.
https://doi.org/10.1182/blood.V130.Suppl_1.4421.4421
Published: 2017
Journal Articles

Gfi1 Transcription Factor Is a Pro-Survival Molecule in Multiple Myeloma Cells

Denise Toscani, PhD, Cheolkyu Park, PhD, Fengming Wang, DDS, PhD, Judith Anderson, Nicola Giuliani, MD, PhD, G. David Roodman, MD PhD, Daniela Nicoleta Petrusca, PhD
Journal: Blood
Blood (2016) 128 (22): 4422.
https://doi.org/10.1182/blood.V128.22.4422.4422
Published: 2016